Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation

Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation for Long-term Use

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01232335

Acronym

ENSURE

Enrollment

1500

Registered

2010-11-02

Start date

2010-01-31

Completion date

2013-05-31

Last updated

2013-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial Asthma

Keywords

bronchial asthma, Symbicort, long term use,

Brief summary

The purpose of this study is to confirm the safety profile for long term treatment and maximize doses and the control status on bronchial asthma in daily clinical usage

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients treated with Symbicort for the first time possibly at the higher dose due to bronchial asthma

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
Incidence of Adverse Events	Range of one year

Secondary

Measure	Time frame
The level of asthma control under long-term use	At the end of 24 weeks

Countries

Japan

Outcome results